The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / A View of Industry from the Inside

A View of Industry from the Inside

April 13, 2011 • By Mary Pinkowish

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Dr. Finck says she that she felt understanding on the part of her colleagues who stayed in academics and clinical practice when she left, and she credits the physicians who transitioned from academic rheumatology to industry before her for smoothing the way. “People gave them a tough time and looked at them as turncoats,” she says, adding that when she left, it was understood that she did so because of the grant situation. “We looked up to them, and I hope the generation that comes after ours looks up to us in the same way.”

You Might Also Like
  • Industry Support & Quality Initiatives
  • Industry Ties Common among Nonprofit Patient Advocacy Groups
  • Obama Nominee to Lead FDA Defends Drug Industry Ties
Explore This Issue
April 2011

Mary Desmond Pinkowish is a medical journalist based in New York.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Thinking About Industry?

Advice from Physicians Who Made the Move

The physicians we interviewed have several pieces of advice for their colleagues who are considering a move to industry—or trying to figure out if they are suited to this type of professional life. “It’s a good transition to consider if you like the practical aspects of new drug development and bringing these drugs to patients,” says Dr. Siegel. He adds that, unlike academic medicine, industry work involves lots of adherence to large-scale, high-quality process. “All of your documentation must be consistent, because the FDA will go over all the records with a fine-tooth comb. Even if the drug has been shown to be safe and effective, it may not get approved if there are problems with the documentation. You need to be comfortable working with the groups responsible for this documentation,” says Dr. Siegel.

Dr. Davis recommends spending time doing the research that will allow you to answer the question, “Is this for me?”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Learn as much as possible about the industry, as well as individual companies,” says Dr. Davis. “Be open, and talk to as many physicians as possible with different positions inside these companies,” he adds.

“There are so many possible roles for physicians, including early development, late development, regulatory affairs, drug safety, and clinical operations,” Dr. Davis points out, adding that it’s beneficial to speak with people in several areas to determine which particular area might be a good match for your interests and experience.

Dr. Davis also recommends speaking to people in small, midsize, and large companies. Each will have a distinct culture, he says, as well as a distinct approach to risk in drug development. Dr. Siegel agrees, adding that it’s worth carefully investigating whether a specific company specializes in particular disease classes or tilts towards innovative drug development as opposed to working with established drug classes. On both counts, the company’s goals should mirror your own interests and expertise.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Career Development, Professional Topics, Workforce Tagged With: Career development, Industry, rheumatologistIssue: April 2011

You Might Also Like:
  • Industry Support & Quality Initiatives
  • Industry Ties Common among Nonprofit Patient Advocacy Groups
  • Obama Nominee to Lead FDA Defends Drug Industry Ties
  • The Forward View in Rheumatology

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Patient & Caregiver Resources

Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.

View Patient & Caregiver Resources »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)